Purchases and Sales Made in Q4 2024 in Regulus Therapeutics Inc. (RGLS)
This table provides information about the institutional ownership of Regulus Therapeutics Inc. (RGLS) during Q4 2024. The information is specifically focused on institutions that hold shares of Regulus Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
BUY
|
- |
5.66K+ 27.21% |
$7.92K - $9.68K
|
26.5K
$31.5K
|
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
BUY
|
- |
760New |
$1.06K - $1.3K
|
760
$904
|
|
|
Feb 05, 2025
Q4 2024
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
412New |
$577 - $705
|
412
$490
|
|
|
Feb 10, 2025
Q4 2024
|
Commonwealth Equity Services, LLC
|
BUY
|
- |
200+ 1.74% |
$280 - $342
|
11.7K
$13.9K
|
|
|
Feb 04, 2025
Q4 2024
|
Cwm, LLC
|
BUY
|
- |
110+ 28.5% |
$154 - $188
|
496
$590
|
|
|
Feb 07, 2025
Q4 2024
|
Ever Source Wealth Advisors, LLC
|
BUY
|
- |
82New |
$115 - $140
|
82
$97.6
|
|
|
Feb 06, 2025
Q4 2024
|
Victory Capital Management Inc
|
SELL
|
- |
-8.98K- 2.25% |
$12.6K - $15.4K
|
390K
$464K
|
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-15K- 20.09% |
$20.9K - $25.6K
|
59.5K
$70.8K
|